CX3CL1 and breast cancer: In breast cancer studies, CX3CL1 was found to have a possible role in tumor metastasis [17,18], and high CX3CL1 expression correlates with good prognosis in breast cancer [19] and can also be used as one of the indications for immunomodulatory therapy.